Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rieneke van de Ven

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of Leukocyte Biology|July 22, 2017
Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesDieke van Dinther, Dorian A Stolk, Rieneke van de Ven, et al.
Journal of Leukocyte Biology|September 12, 2009
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancerRieneke van de Ven, Ruud Oerlemans, Joost W van der Heijden, et al.
Journal of Leukocyte Biology|April 26, 2008
Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functionsSaskia J A M Santegoets, Susan Gibbs, Kim Kroeze, et al.
Journal of Translational Medicine|April 17, 2014
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsWei Ye, Yun Xing, Christopher Paustian, et al.
Cancer Immunology, Immunotherapy : CII|March 25, 2011
High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line modelRieneke van de Ven, Sue Ellen Verbrugge, Anneke W Reurs, et al.
Cancers|January 11, 2025
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage DiseaseIrene H Nauta, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiationRieneke van de Ven, Mariska C de Jong, Anneke W Reurs, et al.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Human Gene Therapy|January 20, 2021
Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in MelanomaIoanna Milenova, Marta Lopez Gonzalez, Dafne C A Quixabeira, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2011
Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapyRieneke van de Ven, Anneke W Reurs, Pepijn G J T B Wijnands, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of Leukocyte Biology|July 22, 2017
Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesDieke van Dinther, Dorian A Stolk, Rieneke van de Ven, et al.
Journal of Leukocyte Biology|September 12, 2009
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancerRieneke van de Ven, Ruud Oerlemans, Joost W van der Heijden, et al.
Journal of Leukocyte Biology|April 26, 2008
Transcriptional profiling of human skin-resident Langerhans cells and CD1a+ dermal dendritic cells: differential activation states suggest distinct functionsSaskia J A M Santegoets, Susan Gibbs, Kim Kroeze, et al.
Journal of Translational Medicine|April 17, 2014
Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cellsWei Ye, Yun Xing, Christopher Paustian, et al.
Cancer Immunology, Immunotherapy : CII|March 25, 2011
High susceptibility of c-KIT+CD34+ precursors to prolonged doxorubicin exposure interferes with Langerhans cell differentiation in a human cell line modelRieneke van de Ven, Sue Ellen Verbrugge, Anneke W Reurs, et al.
Cancers|January 11, 2025
Richness for Tumor-Infiltrating B-Cells in the Oral Cancer Tumor Microenvironment Is a Prognostic Factor in Early-Stage Disease and Improves Outcome in Advanced-Stage DiseaseIrene H Nauta, Dennis N L M Nijenhuis, Sonja H Ganzevles, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 20, 2006
Dendritic cells require multidrug resistance protein 1 (ABCC1) transporter activity for differentiationRieneke van de Ven, Mariska C de Jong, Anneke W Reurs, et al.
Oncoimmunology|December 8, 2018
Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancerRieneke van de Ven, Traci L Hilton, Hong-Ming Hu, et al.
Human Gene Therapy|January 20, 2021
Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in MelanomaIoanna Milenova, Marta Lopez Gonzalez, Dafne C A Quixabeira, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2011
Exposure of CD34+ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapyRieneke van de Ven, Anneke W Reurs, Pepijn G J T B Wijnands, et al.
Pageof 6